Colfax Corp. (CFX) Tops Q3 EPS by 3c, Offers Q4 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Colfax Reports Third Quarter 2020 Results
October 29, 2020 6:00 AM EDTReported $0.12 EPS from continuing operations and achieved $0.41 of adjusted EPSImproved sales momentum with Medical Technology segment achieving 2% reported growth, and 1% organic growthFabrication Technology segment 21% decremental margin contributed to solid Company profit and cash flow performanceSigned definitive agreement to acquire extremity product lines with annual revenue of $20 million
ANNAPOLIS JUNCTION, MD, Oct. 29, 2020 (GLOBE NEWSWIRE) -- Â Colfax Corporation (NYSE: CFX), a leading diversified technology company, today announced its financial results for the third quarter of 2020.
The Company reported net income from continuing... More
